Rheumatoid Arthritis: Epigenetic Drug Targets

Rheumatoid arthritis (RA) is a chronic destructive inflammatory disease that is characterized by severe swelling, pain and stiffness of the joints. While a number of successful immunotherapies, such as anti-TNF, CTLA-4Ig and anti-CD20, have revolutionized the treatment of RA in recent years, many patients still fail to respond sufficiently to treatment. Written by Adam P. Cribbs, Marc Feldmann and Udo Oppermann (University of Oxford), the Rheumatoid Arthritis Life Science Poster summarizes the pathology of rheumatoid arthritis and the inflammatory processes involved, as well as providing insight into some of the epigenetic modifications associated with the disease.

This poster is part of our range of life science posters authored by leading experts in the field. Summarizing key areas of research, these posters provide a colorful and informative resource. 

We invite you to request or download your copy today!